Judge again thwarts class certification against Takeda, Teva and others
Value Drug has once again failed to provide evidence that certifying a class of purchasers of wholesale gout medication is warranted, a Pennsylvania federal judge has said.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10